Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Nevo

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2022
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN)Ohad Atia, Gili Focht, Rona Lujan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2021
Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN CohortOhad Atia, Noa Asayag, Gili Focht, et al.
European Journal of Epidemiology|December 22, 2017
Utility of inverse probability weighting in molecular pathological epidemiologyLi Liu, Daniel Nevo, Reiko Nishihara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease ExacerbationRaffi Lev-Tzion, Gili Focht, Rona Lujan, et al.
Gastroenterology|February 8, 2024
Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus CohortRona Lujan, Rachel Buchuk, Gili Focht, et al.
Inflammatory Bowel Diseases|February 8, 2024
Predictors of Complicated Disease Course in Adults and Children With Crohn's Disease: A Nationwide Study from the epi-IIRNOhad Atia, Rona Lujan, Rachel Buchuk, et al.
Inflammatory Bowel Diseases|May 20, 2024
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRNOhad Atia, Rachel Buchuk, Rona Lujan, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRNOhad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Gut|January 27, 2025
Risk factors for pancreatic cancer in individuals with intraductal papillary mucinous neoplasms and no high-risk stigmata during up to 5 years of surveillance: a prospective longitudinal cohort studyTsuyoshi Hamada, Hiroki Oyama, Daniel Nevo, et al.
Journal of Crohn'S & Colitis|December 14, 2021
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRNOhad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Journal of Pediatric Gastroenterology and Nutrition|February 22, 2022
Perianal Crohn Disease Is More Common in Children and Is Associated With Complicated Disease Course Despite Higher Utilization of Biologics: A Population-based Study From The epidemiology group of the Israeli IBD Research Nucleus (epiIIRN)Ohad Atia, Gili Focht, Rona Lujan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 12, 2021
Perianal Crohn's Disease Is Associated With Poor Disease Outcome: A Nationwide Study From the epiIIRN CohortOhad Atia, Noa Asayag, Gili Focht, et al.
European Journal of Epidemiology|December 22, 2017
Utility of inverse probability weighting in molecular pathological epidemiologyLi Liu, Daniel Nevo, Reiko Nishihara, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 26, 2021
COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease ExacerbationRaffi Lev-Tzion, Gili Focht, Rona Lujan, et al.
Gastroenterology|February 8, 2024
Early Initiation of Biologics and Disease Outcomes in Adults and Children With Inflammatory Bowel Diseases: Results From the Epidemiology Group of the Nationwide Israeli Inflammatory Bowel Disease Research Nucleus CohortRona Lujan, Rachel Buchuk, Gili Focht, et al.
Inflammatory Bowel Diseases|February 8, 2024
Predictors of Complicated Disease Course in Adults and Children With Crohn's Disease: A Nationwide Study from the epi-IIRNOhad Atia, Rona Lujan, Rachel Buchuk, et al.
Inflammatory Bowel Diseases|May 20, 2024
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRNOhad Atia, Rachel Buchuk, Rona Lujan, et al.
Journal of Crohn'S & Colitis|November 18, 2021
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRNOhad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Gut|January 27, 2025
Risk factors for pancreatic cancer in individuals with intraductal papillary mucinous neoplasms and no high-risk stigmata during up to 5 years of surveillance: a prospective longitudinal cohort studyTsuyoshi Hamada, Hiroki Oyama, Daniel Nevo, et al.
Journal of Crohn'S & Colitis|December 14, 2021
Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRNOhad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Pageof 6